Emergex T Cell-Priming Vaccine Candidate for Betacoronaviruses Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://gyldenpharma.com/emergex-t-cell-priming-vaccine-candidate-for-betacoronaviruses-selected-by-nih-niaid-project-nextgen-for-inclusion-in-clinical-trials/
Research Institution
Gylden Pharma
Short Title
Emergex T Cell-Priming Vaccine Candidate
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh